Adriamycin in Adults with Neoplastic Diseases
It is perhaps inappropriate for my report to follow that of Dr. Bonadonna who has had by far the most extensive experience with adriamycin and whose experience has been substantially better than we have seen.
KeywordsToxicity Depression Lymphoma Leukemia Sarcoma
Unable to display preview. Download preview PDF.
- 2.Di Marco, A., Gaetani, M., Scarpinato, B.: Cancer Chem. Rept. 53, 33–37 (1969).Google Scholar
- 3.Bonadonna, G., Monfardini, S., De Lena, M., Fossati-Bellani, F.: Brit. med. J. 1969 III, 503–506.Google Scholar
- 5.Karnofsky, D. A., Burchenal, J. H.: The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod, C. M. (Ed.): Evaluation of Chemotherapeutic Agents. New York: Columbia University Press 1949.Google Scholar